Revolution Medicines, Inc. ($RVMD)
Filing Information
| Accession Number | 0001835966-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 1, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
18,309
Total Value
$1,628,334.23
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | Common Stock | โ | Sep 29, 2026 | Exercise/Conversion | 6,000 | $58.84 | $353,040.00 | 58,868 | Direct | โ | View Details | |
Chief Development Officer | Common Stock | โ | Sep 29, 2026 | Sale | 2,200 | $200.82 | $441,801.36 | 56,668 | Direct | โ | View Details | |
Chief Development Officer | Common Stock | โ | Sep 29, 2026 | Sale | 1,609 | $201.72 | $324,573.76 | 55,059 | Direct | โ | View Details | |
Chief Development Officer | Common Stock | โ | Sep 29, 2026 | Sale | 1,000 | $202.81 | $202,812.70 | 54,059 | Direct | โ | View Details | |
Chief Development Officer | Common Stock | โ | Sep 29, 2026 | Sale | 1,199 | $203.91 | $244,484.97 | 52,860 | Direct | โ | View Details | |
Chief Development Officer | Common Stock | โ | Sep 29, 2026 | Sale | 301 | $204.72 | $61,621.44 | 52,559 | Direct | โ | View Details | |
Chief Development Officer | Stock Option (Right to Buy) | Derivative | Sep 29, 2026 | Exercise/Conversion | 6,000 | $0.00 | $0.00 | 161,300 | Direct | โ | View Details |